News
DRTS
9.35
-3.31%
-0.32
Weekly Report: what happened at DRTS last week (0608-0612)?
Weekly Report · 1d ago
Alpha Tau Granted FDA Clearance To Expand REGAIN Study For Alpha-DaRT In Glioblastoma Treatment
NASDAQ · 4d ago
Alpha Tau Medical: A Lot Of Shots On Goal
Seeking Alpha · 4d ago
Alpha Tau gets FDA clearance to complete enrollment in REGAIN trial
TipRanks · 5d ago
Alpha Tau Wins FDA Clearance to Complete REGAIN Glioblastoma Trial Enrollment After Strong Interim Data
TipRanks · 5d ago
Alpha Tau Medical Receives FDA Clearance To Proceed With Enrollment Of Final Seven Patients In U.S. REGAIN Trial
Benzinga · 5d ago
Alpha Tau wins FDA clearance to complete enrollment in recurrent glioblastoma REGAIN trial
PUBT · 5d ago
ALPHA TAU MEDICAL - TO RESUME RECRUITMENT FOR REMAINING SEVEN PATIENTS IN REGAIN TRIAL
Reuters · 5d ago
Weekly Report: what happened at DRTS last week (0601-0605)?
Weekly Report · 06/08 09:29
Top Executive Makes Major Move With Alpha Tau Medical Stock
TipRanks · 06/05 02:08
Alpha Tau Medical CFO Raphi Levy disposes of $352,606 in common shares
PUBT · 06/04 18:30
Alpha Tau Medical Price Target Maintained With a $15.00/Share by HC Wainwright & Co.
Dow Jones · 06/04 14:58
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target
Benzinga · 06/04 14:48
Alpha Tau Medical Price Target Raised to $17.00/Share From $15.00 by Barclays
Dow Jones · 06/04 13:08
Alpha Tau Medical Is Maintained at Overweight by Barclays
Dow Jones · 06/04 13:08
Barclays Maintains Overweight on Alpha Tau Medical, Raises Price Target to $17
Benzinga · 06/04 12:58
Alpha Tau price target raised to $17 from $15 at Barclays
TipRanks · 06/04 09:11
Alpha Tau Medical Ltd (DRTS) Receives a Buy from Barclays
TipRanks · 06/04 08:37
Alpha Tau And Tolmar Form Strategic Collaboration In U.S. Prostate Cancer
NASDAQ · 06/04 07:55
More
Webull provides a variety of real-time DRTS stock news. You can receive the latest news about Alpha Tau Medical Ltd through multiple platforms. This information may help you make smarter investment decisions.
About DRTS
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.